|
Johnson Matthey PLC - London-based chemicals maker - Further to announcement in March, completes the sale of its medical device components business for $700 million on a cash, debt free basis. Confirms its intention to return £250 million of the net proceeds from the sale by way of an on-market share buyback programme. This will commence later this week. Current stock price: 1,575.00 pence 12-month change: down 10% Copyright 2024 Alliance News Ltd. All Rights reserved.
|
